Skip to content
Review

Mechanistic and molecular insights into emerging anti-virulence therapeutics.

Aug 2026 · Infection · 0 citations · 78 references
Medicine

TL;DR

This review provides an integrated overview of emerging AV approaches targeting quorum sensing, type III secretion systems, biofilm development, adhesion, toxin activity, iron acquisition, and host-pathogen interactions and suggests that AV therapy is best positioned as a precision anti-infective strategy.

View source

Similar papers

Review Open access Sep 2026

Host-directed therapeutics against antimicrobial-resistant bacterial infections: emerging roles of multi-omics and systems biology

The rapid emergence and global dissemination of antimicrobial resistance (AMR), coupled with the limited development of new antimicrobial agents, have intensified concerns regarding a major global public health crisis. Although antibiotic resistance is primarily driven by microbial mechanisms, host immune and inflammat...

Sarmistha Saha, N. Sachivkina, Oksana Gizinger et al. · 0 citations
Review Open access Sep 2026

Antimicrobial peptides in the era of resistance: integrating AI-driven design, host-microbe interactions, and nanotechnological delivery

This review synthesizes recent advances in AMP research, focusing on their structural diversity, mechanistic interactions with microbial membranes, and immunomodulatory roles in shaping host-microbe dynamics, and establishes a framework for overcoming current limitations.

Zhu-Yu Hua, Xu Xia, Khan Qaisar et al. · 0 citations
Review Open access Sep 2026

Nanomedicine against antimicrobial resistance: mechanistic insights and next-generation therapeutic potential

This review comprehensively examines resistance mechanisms across major microbial pathogens and discusses the evolution of nanomedicine as an advanced platform for combating AMR, highlighting the synergistic interactions between nanomaterials and conventional antimicrobial agents that enhance therapeutic efficacy and r...

Vishal L. Handa, Benedict B. Vyas, Abhishek Padhi et al. · 0 citations
Review Sep 2026

Advances in Antimicrobial Peptides: Design, Mechanism, and Clinical Application-A Critical Review.

This review explores how computational design, artificial intelligence, and peptidomimetics can generate next-generation AMPs with enhanced stability and reduced toxicity, framing their role in future antimicrobial strategies.

Shesham Kumari, Ranjeet Kumar, Manish Singh et al. · 0 citations
Review Sep 2026

Non-antibiotic therapeutic approaches for antimicrobial resistance: current evidence and future directions.

This review summarizes the current evidence on non-antibiotic therapeutics including bacteriophages, antimicrobial peptides, anti-virulence agents, monoclonal antibodies, microbiome-based therapies, CRISPR-Cas systems, nanoparticles, photodynamic therapy, repurposed non-antibiotic drugs and combination strategies.

Bharath Kumar Ganesan, A. Mishra, Debasish Hota et al. · 0 citations
Review Sep 2026

PLANT-DERIVED THERAPEUTICS AS A NOVEL STRATEGY TO COMBAT ANTIMICROBIAL RESISTANCE: CURRENT ADVANCES AND FUTURE PERSPECTIVE

Overall, plant-derived therapeutics represent a promising and sustainable avenue for the discovery and development of complementary antimicrobial strategies to address the growing global burden of AMR.

Deeksha Rathor, Pushpendra Kumar, Km. Neha et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.